• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Acumen Pharmaceuticals

Alps parachute rainbow mountains
Biotech

Trevena teeters on edge with C-suite shakedown—Chutes & Ladders

Trevena teeters on edge with C-suite shakedown. Blackstone-founded Anthos fills exec team with industry vets. Former First Lady tapped as Celltex CEO.
Darren Incorvaia , Zoey Becker Nov 8, 2024 8:30am
photo of parachutes over a river

Ex-Eisai leader to be new NextPoint CEO—Chutes & Ladders

Feb 2, 2024 9:30am
Alzheimers brain

Acumen posts early Alzheimer's data for next-gen Leqembi rival

Jul 17, 2023 5:32am
stock market graph

Acumen surges in IPO debut, raises $160M for Alzheimer's drug

Jul 1, 2021 2:43pm
Nasdaq

Acumen prices IPO, targets phase 2 data on amyloid-beta prospect

Jun 25, 2021 8:30am
Cash

'Big hole' no more as Aduhelm opens AD drug funding 'floodgates'

Jun 10, 2021 11:03am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings